MaxCyte, Inc. (AIM:MXCT)
London
· Delayed Price · Currency is GBP · Price in GBX 180.00
-21.00 (-10.45%)
May 9, 2025, 4:40 PM GMT+1
MaxCyte Market Cap
MaxCyte has a market cap or net worth of 213.70 million as of May 9, 2025. Its market cap has decreased by -30.61% in one year.
Market Cap
213.70M
Enterprise Value
121.25M
Revenue
29.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
180.00
Market Cap Chart
Since March 29, 2016, MaxCyte's market cap has increased from 33.25M to 213.70M, an increase of 542.61%. That is a compound annual growth rate of 22.64%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.88B |
| GSK plc | 56.05B |
| Haleon | 36.35B |
| Smith & Nephew | 9.26B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.32B |